1-3 of 3
Peter B. Dervan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors

Jerzy O. Szablowski, Jevgenij A. Raskatov, Peter B. Dervan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (4): 608–617.
https://doi.org/10.1158/1535-7163.MCT-15-0719
Published: 05 April 2016
View article titled, An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors
Open the PDF for An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors in another window
Includes: Supplementary data
Journal Articles

Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element

Nicholas G. Nickols, Jerzy O. Szablowski, Amanda E. Hargrove, Benjamin C. Li, Jevgenij A. Raskatov, Peter B. Dervan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5): 675–684.
https://doi.org/10.1158/1535-7163.MCT-12-1040
Published: 08 May 2013
View article titled, Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element
Open the PDF for Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element in another window
Includes: Supplementary data
Journal Articles

Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia

C. James Chou, Michelle E. Farkas, Sherry M. Tsai, David Alvarez, Peter B. Dervan, Joel M. Gottesfeld
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 769–778.
https://doi.org/10.1158/1535-7163.MCT-08-0130
Published: 15 April 2008
View article titled, Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia
Open the PDF for Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia in another window
Includes: Supplementary data